Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients.

Clinical trial NCT04652206 · UNKNOWN

Trial details

NCT number: NCT04652206
Sponsor: Scandion Oncology A/S
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma Locally Advanced Pancreatic Adenocarcinoma Inoperable Disease Localized Pancreatic Adenocarcinoma

Start date: 2020-10-27
Primary completion: 2022-03-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.